Comparable stake leader
MiCo IVD Holdings, LLC
SEC ownership of TRINITY BIOTECH PLC
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000888721.
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
26/28
Latest evidence
30 Apr 2026
- Public ticker
- TRIB on Nasdaq
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
MiCo IVD Holdings, LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
26 of 28
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
MiCo IVD Holdings, LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Apr 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0000888721
- Issuer location
- Wicklow
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of TRINITY BIOTECH PLC (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
MiCo IVD Holdings, LLC
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
26/28
Latest evidence
30 Apr 2026
13D/G
13F
3/4/5
Lead comparable stake: 17%
2 rows are not safely comparable across share classes.
13D/G row: MiCo IVD Holdings, LLC
Showing 1-8 of 28 holder rows.
Quick read
MiCo IVD Holdings, LLC leads the comparable SEC ownership view at 17%.
26 of 28 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens MiCo IVD Holdings, LLC's linked filing trail.
Comparable ownership
Top 5
MiCo IVD Holdings, LLC
17%
PERCEPTIVE ADVISORS LLC
9.9%
Novus Diagnostics Ltd.
6%
HUNTER ASSOCIATES INVESTMENT MANA...
0%
Yorkville Advisors Global, LP
0%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 28 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MiCo IVD Holdings, LLC |
13D/G
|
17%
|
$62,505,648
69,450,720 shares
|
$0 | 08 Dec 2025 |
| PERCEPTIVE ADVISORS LLC |
13D/G
|
9.9%
|
$2,431,054,169
3,424,019,957 shares
|
+$1,392,282,813 | 30 Apr 2026 |
| Novus Diagnostics Ltd. |
13D/G
|
6%
|
—
1,119,988 shares
|
$0 | 23 Dec 2025 |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC |
13F
Company
|
0%
|
$292,000
536,210 shares
|
— | 31 Mar 2026 |
| Yorkville Advisors Global, LP |
13F
Company
|
0%
|
$121,995
225,000 shares
|
— | 31 Mar 2026 |
| Williams & Novak, LLC |
13F
Company
|
0%
|
$64,371
107,643 shares
|
— | 31 Mar 2026 |
| Virtu Financial LLC |
13F
Company
|
0%
|
$14,000
26,676 shares
|
— | 31 Mar 2026 |
| Moss Adams Wealth Advisors LLC |
13F
Company
|
0%
|
$13,917
25,666 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 16 Jun 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-5 of 5 reporting-owner rows connected to TRINITY BIOTECH PLC. Open a relationship link for the CIK-to-CIK filing trail.
Rows
5
Largest Forms 3/4/5 holder
Andrew Omidvar
Net 12M change
$0
Latest report
18 Mar 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Andrew Omidvar | Director | Mixed | 18 Mar 2026 | |||
| John Gillard | Director | Mixed | 18 Mar 2026 | |||
| John Paul Tivnan | Director | Mixed | 18 Mar 2026 | |||
| Paul Murphy | Interim CFO | Mixed | 18 Mar 2026 | |||
| Ronan O'Caoimh | Director | Mixed | 18 Mar 2026 |
Recent insider transactions for TRINITY BIOTECH PLC
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Ronan O'Caoimh | TRIB | ADS | 0 | 486,208 | 18 Mar 2026 | Direct | ||||
| John Gillard | TRIB | ADS | 0 | 10,000 | 18 Mar 2026 | Direct |
* marks a reported price that did not pass the local price check.